These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 8884775)

  • 1. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
    You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
    Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
    You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats.
    You ZB; Herrera-Marschitz M; Nylander I; Goiny M; Kehr J; Ungerstedt U; Terenius L
    Brain Res; 1996 Feb; 710(1-2):241-8. PubMed ID: 8963665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
    You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
    Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat.
    Bustamante D; You ZB; Castel MN; Johansson S; Goiny M; Terenius L; Hökfelt T; Herrera-Marschitz M
    J Neurochem; 2002 Nov; 83(3):645-54. PubMed ID: 12390526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides.
    You ZB; Herrera-Marschitz M; Terenius L
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1307-15. PubMed ID: 10454508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition.
    You ZB; Nylander I; Herrera-Marschitz M; O'Connor WT; Goiny M; Terenius L
    Neuroscience; 1994 Nov; 63(2):415-25. PubMed ID: 7891855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
    Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
    Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis.
    You ZB; Saria A; Fischer-Colbrie R; Terenius L; Goiny M; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):717-24. PubMed ID: 8971731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis.
    You ZB; Pettersson E; Herrera-Marschitz M; Hökfelt T; Terenius L; Nylander I; Goiny M; Hughes J; O'Connor WT; Ungerstedt U
    Neuroreport; 1994 Nov; 5(17):2301-4. PubMed ID: 7881050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
    Abarca J; Bustos G
    Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids.
    Keefe KA; Sved AF; Zigmond MJ; Abercrombie ED
    J Neurochem; 1993 Nov; 61(5):1943-52. PubMed ID: 7901337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
    Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain.
    Ge J; Long SK; Kilpatrick IC
    Eur J Pharmacol; 1998 Mar; 345(2):163-70. PubMed ID: 9600632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra.
    Castro SL; Zigmond MJ
    Brain Res; 2001 May; 901(1-2):47-54. PubMed ID: 11368949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
    Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis.
    Globus MY; Busto R; Dietrich WD; Martinez E; Valdes I; Ginsberg MD
    J Neurochem; 1988 Nov; 51(5):1455-64. PubMed ID: 2902196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat.
    Smolders I; De Klippel N; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 1995 Sep; 284(1-2):83-91. PubMed ID: 8549640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The release of amino acids from rat neostriatum and substantia nigra in vivo: a dual microdialysis probe analysis.
    Bianchi L; Colivicchi MA; Bolam JP; Della Corte L
    Neuroscience; 1998 Nov; 87(1):171-80. PubMed ID: 9722150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine.
    Roy E; Côté PY; Grégoire L; Parent A; Bédard PJ
    Neuroscience; 1995 May; 66(2):413-25. PubMed ID: 7477882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.